Trial intelligence / Profile preview

Influence of OATP1B1 Genotype on Rosuvastatin PK and Lipid Profiles

NCT01218347Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Oct 2010
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of rosuvastatin in hypercholesterolemia, sponsored by Seoul National University Hospital. Primary endpoints: Time to Maximum Plasma Concentration at Day 21, Maximum Plasma Concentration at Day 21 and 1 more. Started Oct 2010; status: completed.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01218347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01218347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call